The book The Checklist Manifesto by Atul Gawande remains on my personal list of top 100 favourites even after a decade. Atul Gawande uses the example of checklists used by pilots to drive home his point about the importance of checklists in surgical practice…
Read more
The intersection of biotechnology and artificial intelligence (AI) represents one of the most promising frontiers of innovation, with industry leaders like Nvidia, Google, and Microsoft betting billions on its potential. This convergence is poised to revolutionize…
Read more
At a moment when artificial intelligence (AI) is reshaping the boundaries of multiple disciplines, the notable research spearheaded by Edward Chang, MD, at the UCSF Weill Institute for Neurosciences, brings a unique and profound contribution to the field. By…
Read more
The Indian healthcare sector, with its vast and varied landscape, faces challenges akin to those seen in the U.S., albeit within a different context. The financial performance of the University of Pittsburgh Medical Center (UPMC) in 2023 provides valuable insights…
Read more
The Indian healthcare scenario presents a fascinating study of contrasts and opportunities, particularly when analysing the business metrics and strategies of leading hospital chains such as Max Healthcare and Krishna Institute of Medical Sciences (KIMS). The…
Read more
A recent Study by Alexander V. Eriksen, M.D., and Sören Möller, M.Sc., Ph.D., featured in the New England Journal of Medicine, delves into the capabilities of Generative Pretrained Transformer 4 (GPT-4), a cutting-edge Artificial Intelligence (AI) model, in…
Read more
The integration of Artificial Intelligence (AI) into the medical science field represents a pivotal moment in healthcare, offering a pathway either toward unprecedented growth and innovation or toward challenges marked by job displacement and economic uncertainties….
Read more
In a landmark deal within the Indian pharmaceutical sector, ERIS Lifesciences has acquired the India-branded formulations business of Biocon Biologics for Rs. 1242 Crore ($150 million), equivalent to 3.4 times the revenue. This acquisition marks ERIS Lifesciences’…
Read more
Most Commented